Sanofi-aventis is one of the world’s leading pharmaceutical companies.

The Group operates in more than 100 countries, with around 100,000 employees. It has approximately 17,600 scientists working in over 28 research centers in three continents to create innovative therapeutic treatments.

Our global headquarters are in Paris, France.

Sanofi-aventis provides innovative therapeutic solutions to fight disease in seven major areas of expertise, contributing in a significant way to the improvement of the health and well-being of patients around the world, and in Singapore in particular: 

• Cardiovascular
• Thrombosis 
• Oncology
• Central Nervous System  
• Metabolic Disorders 
• Internal Medicine  
• Vaccines        

The sanofi-aventis portfolio of marketed products includes several medicines that are world leaders in their respective classes, in the areas of thrombosis, cardiovascular diseases, bone diseases, sleep disorders, epilepsy, diabetes and cancer. 

With more than 26 research centres on three continents, sanofi-aventis coordinates its Research and Development on a worldwide basis.  Sanofi-aventis possesses one of the richest and most innovative portfolios in the industry with a large number of compounds and vaccines under development, half of which are in advanced stages of clinical investigations (phases II and III).

The group dedicates its research to finding innovative, effective and safe medicines that provide new therapeutic solutions to patients, Because Health Matters...


For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.